CBX3P1

Across TCGA pan-cancer cohorts, CBX3P1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of CBX3P1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where CBX3P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CBX3P1 is over-expressed in tumor.

STAD, HNSC, and COAD are the cancer types where CBX3P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CBX3P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	All	+0.188	.001	6	view →
HNSC	Male	All	+0.062	.002	6	view →
COAD	All	All	+0.093	.026	4	view →
BRCA	All	All	+0.050	.003	4	view →
KIRP	All	II,III,IV	+0.069	.012	3	view →
LIHC	All	All	+0.020	.005	3	view →
ESCA	All	II,III,IV	+0.205	<.001	2	view →
BLCA	All	All	+0.115	.020	2	view →
LUAD	All	All	+0.105	.008	2	view →
UCEC	All	All	+0.100	.038	2	view →
KICH	Male	All	+0.038	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

CBX3P1–STAD

Open the STAD breakdown →